Literature DB >> 22703631

Parkinson disease and Alzheimer disease: environmental risk factors.

J Campdelacreu1.   

Abstract

INTRODUCTION: The purpose of this review is to update and summarise available evidence on environmental risk factors that have been associated with risk of Parkinson disease (PD) or Alzheimer disease (AD) and discuss their potential mechanisms. DEVELOPMENT: Evidence consistently suggests that a higher risk of PD is associated with pesticides and that a higher risk of AD is associated with pesticides, hypertension and high cholesterol levels in middle age, hyperhomocysteinaemia, smoking, traumatic brain injury and depression. There is weak evidence suggesting that higher risk of PD is associated with high milk consumption in men, high iron intake, chronic anaemia and traumatic brain injury. Weak evidence also suggests that a higher risk of AD is associated with high aluminium intake through drinking water, excessive exposure to electromagnetic fields from electrical grids, DM and hyperinsulinaemia, obesity in middle age, excessive alcohol consumption and chronic anaemia. Evidence consistently suggests that a lower risk of PD is associated with hyperuricaemia, tobacco and coffee use, while a lower risk of AD is associated with moderate alcohol consumption, physical exercise, perimenopausal hormone replacement therapy and good cognitive reserve. Weak evidence suggests that lower risk of PD is associated with increased vitamin E intake, alcohol, tea, NSAIDs, and vigorous physical exercise, and that lower risk of AD is associated with the Mediterranean diet, coffee and habitual NSAID consumption.
CONCLUSIONS: Several environmental factors contribute significantly to risk of PD and AD. Some may already be active in the early stages of life, and some may interact with other genetic factors. Population-based strategies to modify such factors could potentially result in fewer cases of PD or AD.
Copyright © 2012 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Enfermedad de Alzheimer; Enfermedad de Parkinson; Environmental risk factors; Environmental toxins. Parkinson disease; Factores de riesgo ambientales; Factores protectores; Interacción; Interaction; Protective factors; Tóxicos ambientales

Mesh:

Year:  2012        PMID: 22703631     DOI: 10.1016/j.nrl.2012.04.001

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  37 in total

Review 1.  The Potential Role of BMAA in Neurodegeneration.

Authors:  Tracie Caller; Patricia Henegan; Elijah Stommel
Journal:  Neurotox Res       Date:  2017-06-13       Impact factor: 3.911

2.  Quantitative mapping of trimethyltin injury in the rat brain using magnetic resonance histology.

Authors:  G Allan Johnson; Evan Calabrese; Peter B Little; Laurence Hedlund; Yi Qi; Alexandra Badea
Journal:  Neurotoxicology       Date:  2014-03-11       Impact factor: 4.294

Review 3.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

4.  Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.

Authors:  Yaohui Ni; Hua Huang; Yaqin Chen; Maohong Cao; Hongzhi Zhou; Yuanyuan Zhang
Journal:  Cell Mol Neurobiol       Date:  2016-05-05       Impact factor: 5.046

Review 5.  Inflammation in CNS neurodegenerative diseases.

Authors:  Jodie Stephenson; Erik Nutma; Paul van der Valk; Sandra Amor
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

6.  Insulin-associated neuroinflammatory pathways as therapeutic targets for traumatic brain injury.

Authors:  Christian D Cerecedo-López; Jennifer H Kim-Lee; Diana Hernandez; Sandra A Acosta; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2013-12-01       Impact factor: 1.538

7.  Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Neurobiol Dis       Date:  2013-02-27       Impact factor: 5.996

Review 8.  Toxicity and infectivity: insights from de novo prion formation.

Authors:  Brett T Wisniewski; Jaya Sharma; Emily R Legan; Emily Paulson; Stephen J Merrill; Anita L Manogaran
Journal:  Curr Genet       Date:  2017-08-30       Impact factor: 3.886

Review 9.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

10.  Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.

Authors:  Vivek Lawana; Se Young Um; Rachel M Foguth; Jason R Cannon
Journal:  Neurotoxicology       Date:  2020-10-13       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.